Imago BioSciences, Inc. Operating Expenses
Imago BioSciences, Inc. reported Operating Expenses of $17.55 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2022-11-09
- Imago BioSciences, Inc. operating expenses for the quarter ending 2022-09-30 was $17.55M, a 49.73% increase year-over-year.
- Imago BioSciences, Inc. operating expenses for the quarter ending 2022-06-30 was $14.02M, a 58.52% increase year-over-year.
- Imago BioSciences, Inc. operating expenses for the quarter ending 2022-03-31 was $16.51M, a 131.02% increase year-over-year.
- Imago BioSciences, Inc. operating expenses for the quarter ending 2021-12-31 was $14.81M, a 166.15% increase year-over-year.
- Imago BioSciences, Inc. operating expenses for fiscal 2021 was $42.52M, a 135.30% increase from fiscal 2020.
- Imago BioSciences, Inc. operating expenses for fiscal 2020 was $18.07M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2022-09-30 | $17.55M 10-Q · filed 2022-11-09 | $31.56M derived: sum of 2 quarters · filed 2022-11-09 | $48.08M 10-Q · filed 2022-11-09 | $62.89M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | $14.02M 10-Q · filed 2022-08-12 | $30.53M 10-Q · filed 2022-08-12 | $45.34M derived: sum of 3 quarters · filed 2022-08-12 | $57.06M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-03-31 | $16.51M 10-Q · filed 2022-05-12 | $31.33M derived: sum of 2 quarters · filed 2022-05-12 | $43.05M derived: sum of 3 quarters · filed 2022-11-09 | $51.89M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-12-31 | $14.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $26.53M derived: sum of 2 quarters · filed 2022-11-09 | $35.38M derived: sum of 3 quarters · filed 2022-11-09 | $42.52M 10-K · filed 2022-03-24 |
| 2021-09-30 | $11.72M 10-Q · filed 2022-11-09 | $20.56M derived: sum of 2 quarters · filed 2022-11-09 | $27.71M 10-Q · filed 2022-11-09 | $33.28M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $8.84M 10-Q · filed 2022-08-12 | $15.99M 10-Q · filed 2022-08-12 | $21.56M derived: sum of 3 quarters · filed 2022-08-12 | $25.87M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $7.15M 10-Q · filed 2022-05-12 | $12.71M derived: sum of 2 quarters · filed 2022-05-12 | $17.02M derived: sum of 3 quarters · filed 2022-05-12 | $21.03M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $5.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $9.88M derived: sum of 2 quarters · filed 2022-03-24 | $13.88M derived: sum of 3 quarters · filed 2022-03-24 | $18.07M 10-K · filed 2022-03-24 |
| 2020-09-30 | $4.31M 10-Q · filed 2021-11-10 | $8.31M derived: sum of 2 quarters · filed 2021-11-10 | $12.51M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $4.00M 10-Q · filed 2021-08-19 | $8.20M 10-Q · filed 2021-08-19 |